Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome

Recruiting N/A Interventional Study
Age Related Cataracts Pseudoexfoliation Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Medical University of Vienna · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this study is to compare the surgical outcomes of the two IOL implantation methods for eyes with cataract and PEX in a single-center and with highly experienced surgeons. The goal is to acquire relevant information regarding these two IOL implantation techniques, which will help surgeons to decide which approach to choose, ultimately resulting in a benefit for patients with PEX syndrome…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 60 - 100 * Necessity for bilateral cataract surgery with pseudoexfoliation syndrome * willing to give informed consent and follow-up the duration of study Exclusion Criteria: * Endstage glaucoma * Christalline lens sub/ luxation * active inflammatory diseases of the eye
Contacts

Claudette ABELA-FORMANEK, Prof.Dr.

+43(0)14040079680

claudette.abela-formanek@meduniwien.ac.at

CONTACT

Markus Schranz, Dr.

+43(0)14040079690

markus.schranz@meduniwien.ac.at

CONTACT